This inventor holds 1 USPTO granted patent. Top assignee: Rigel Pharmaceuticals, Incorporated. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Hitoshi Yasumichi: Innovator in Pharmaceutical Compounds
Introduction
Hitoshi Yasumichi is a notable inventor based in Brisbane, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various metabolic disorders.
Latest Patents
Yasumichi holds a patent for 5- or 6-substituted benzofuran-2-carboxamide compounds and methods for using them. This patent relates to specific carboxamide, sulfonamide, and amine compounds, along with their pharmaceutical compositions. The methods described in the patent aim to treat and ameliorate disorders associated with the adiponectin pathway, sphingolipid metabolism, oxidative stress, mitochondrial dysfunction, free radical damage, and metabolic inefficiency, among others. The compounds have specific structures as outlined in the patent documentation.
Career Highlights
Hitoshi Yasumichi is currently associated with Rigel Pharmaceuticals, Incorporated, where he continues to innovate in the pharmaceutical sector. His work focuses on developing new therapeutic solutions that address complex health issues.
Collaborations
Yasumichi collaborates with esteemed colleagues, including Dane A Goff and Donald G Payan, to advance research and development in his field.
Conclusion
Hitoshi Yasumichi's contributions to pharmaceutical innovations highlight his role as a key inventor in developing compounds that address critical health challenges. His work continues to impact the industry positively.